Intra-Cellular Therapies (BSP:I2TC34) Marketable Securities : R$1,672 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Intra-Cellular Therapies Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Intra-Cellular Therapies's Marketable Securities for the quarter that ended in Mar. 2024 was R$1,672 Mil.

Intra-Cellular Therapies's annual Marketable Securities increased from Dec. 2021 (R$1,809 Mil) to Dec. 2022 (R$2,325 Mil) but then declined from Dec. 2022 (R$2,325 Mil) to Dec. 2023 (R$1,716 Mil).

Intra-Cellular Therapies Marketable Securities Historical Data

The historical data trend for Intra-Cellular Therapies's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intra-Cellular Therapies Marketable Securities Chart

Intra-Cellular Therapies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

477.65

3,073.45

1,809.39

2,325.23

1,715.78

Intra-Cellular Therapies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															2,411.48	1,798.76	1,943.97	1,715.78	1,672.24

Intra-Cellular Therapies Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Intra-Cellular Therapies (BSP:I2TC34) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Intra-Cellular Therapies Marketable Securities Related Terms

Thank you for viewing the detailed overview of Intra-Cellular Therapies's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Intra-Cellular Therapies (BSP:I2TC34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intra-Cellular Therapies Inc (BSP:I2TC34) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

ITCI:USA ITCI:Mexico 23I:Germany

Address

430 East 29th Street, New York, NY, USA, 10016

Website

https://www.intracellulartherapies.com

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Intra-Cellular Therapies (BSP:I2TC34) Headlines

No Headlines